title: Monocyte phosphodiesterase abnormalities and dysregulation of lymphocyte function in atopic dermatitis.
abstract: The immunologic aberrations associated with atopic dermatitis include the paradox of reduced cell-mediated immune responses in the setting of increased cell-mediated immunity features that resemble allergic contact dermatitis. In this review, we present evidence that abnormalities in monocytes and Langerhans cells alter the function of T-helper-cell subpopulations to cause the immunologic defects associated with atopic dermatitis. Increased monocyte prostaglandin E2 production inhibits Th1 responses, accentuating interleukin (IL)-4 secretion by Th2 cells. Elevated prostaglandin E2 secretion correlates with abnormally increased cyclic adenosine monophosphate-phosphodiesterase activity in monocytes and this, along with other defective inflammatory cell responses, can be normalized in vitro by phosphodiesterase inhibitors. It appears that in addition to prostaglandin E2, IL-10 acts to regulate the balance between Th1 and Th2 functional responses accounting for many atopic features, including increased IL-4, IL-5, and IL-6 production by T cells; increased IgE synthesis; decreased interferon-gamma production; and impaired cell-mediated immune responses. All of these abnormalities can be related to increased phosphodiesterase activity in atopic monocytes, and inhibition of this key enzyme appears to reverse atopic dermatitis inflammatory abnormalities in vitro and in vivo.
authors.affiliation: Department of Dermatology, Oregon Health Sciences University, Portland, Oregon, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Hanifin
authors.forename: S C
authors.initials: SC
authors.lastname: Chan
mesh_terms: D000818:Animals; D003876:Dermatitis, Atopic / Q000473:pathology / Q000503:physiopathology*; D015232:Dinoprostone / Q000378:metabolism; D006801:Humans; D008214:Lymphocytes / Q000502:physiology*; D009000:Monocytes / Q000201:enzymology*; D009712:Nucleotides, Cyclic / Q000378:metabolism; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D013601:T-Lymphocytes / Q000502:physiology
chemical_list: D009712:Nucleotides, Cyclic; D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases; D015232:Dinoprostone